BAX Baxter International Inc.

Price (delayed)

$77.64

Market cap

$39.3B

P/E Ratio

42.9

Dividend/share

$0.93

EPS

$1.81

Enterprise value

$42.08B

Sector: Healthcare
Industry: Medical Instruments & Supplies
Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL.

Highlights

The quick ratio is up by 12% year-on-year and by 4.5% since the previous quarter
The company's equity rose by 6% QoQ and by 4% YoY
Baxter International's debt has increased by 21% YoY but it has decreased by 2.2% from the previous quarter
BAX's P/E is 43% above its 5-year quarterly average of 29.9 and 3.6% above its last 4 quarters average of 41.4
BAX's net income is down by 37% year-on-year and by 7% since the previous quarter

Key stats

What are the main financial stats of BAX
Market
Shares outstanding
506.23M
Market cap
$39.3B
Enterprise value
$42.08B
Valuations
Price to earnings (P/E)
42.9
Price to book (P/B)
4.86
Price to sales (P/S)
3.46
EV/EBIT
41.95
EV/EBITDA
23.38
EV/Sales
3.69
Earnings
Revenue
$11.41B
EBIT
$1B
EBITDA
$1.8B
Free cash flow
$1.48B
Per share
EPS
$1.81
Free cash flow per share
$2.91
Book value per share
$15.97
Revenue per share
$22.42
TBVPS
$28.87
Balance sheet
Total assets
$19.47B
Total liabilities
$11.31B
Debt
$6.86B
Equity
$8.13B
Working capital
$5.69B
Liquidity
Debt to equity
0.84
Current ratio
2.97
Quick ratio
2.07
Net debt/EBITDA
1.54
Margins
EBITDA margin
15.8%
Gross margin
41.4%
Net margin
8.1%
Operating margin
15.6%
Efficiency
Return on assets
5%
Return on equity
11.8%
Return on invested capital
7.3%
Return on capital employed
6%
Return on sales
8.8%
Dividend
Dividend yield
1.2%
DPS
$0.93
Payout ratio
51.4%

BAX stock price

How has the Baxter International stock price performed over time

Financial performance

How have Baxter International's revenue and profit performed over time
Revenue
$11.41B
Gross profit
$4.73B
Operating income
$1.78B
Net income
$924M
Gross margin
41.4%
Net margin
8.1%
Baxter International's net margin has decreased by 40% YoY and by 6% from the previous quarter
BAX's net income is down by 37% year-on-year and by 7% since the previous quarter
Baxter International's operating income has increased by 18% YoY
The operating margin has increased by 15% YoY

Growth

What is Baxter International's growth rate over time

Valuation

What is Baxter International stock price valuation
P/E
42.9
P/B
4.86
P/S
3.46
EV/EBIT
41.95
EV/EBITDA
23.38
EV/Sales
3.69
BAX's P/E is 43% above its 5-year quarterly average of 29.9 and 3.6% above its last 4 quarters average of 41.4
The EPS has contracted by 36% YoY and by 7% from the previous quarter
BAX's P/B is 19% above its 5-year quarterly average of 4.1 but 12% below its last 4 quarters average of 5.5
The company's equity rose by 6% QoQ and by 4% YoY
BAX's P/S is 9% below its last 4 quarters average of 3.8 but 8% above its 5-year quarterly average of 3.2
The revenue is up by 3.1% year-on-year

Efficiency

How efficient is Baxter International business performance
The ROIC has decreased by 47% YoY and by 3.9% from the previous quarter
The ROA has contracted by 44% YoY and by 9% from the previous quarter
The ROS has contracted by 37% YoY
The company's return on equity fell by 35% YoY and by 8% QoQ

Dividends

What is BAX's dividend history
DPS
$0.93
Dividend yield
1.2%
Payout ratio
51.4%
Recent dividends

Financial health

How did Baxter International financials performed over time
The total assets is 72% more than the total liabilities
The quick ratio is up by 12% year-on-year and by 4.5% since the previous quarter
The total assets has grown by 11% YoY and by 2% from the previous quarter
Baxter International's debt is 16% less than its equity
Baxter International's debt has increased by 21% YoY but it has decreased by 2.2% from the previous quarter
The debt to equity has increased by 17% year-on-year but it has declined by 8% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.